In response to a request to consolidate an apparently mounting group of lawsuits over the chemotherapy drug Taxotere, the New Jersey state court system has asked the bar for feedback on the possible establishment of multi-county litigation.
The litigation involves, as of last month, 353 pending cases against drugmaker Sanofi-Aventis claiming products liability and fraud, and alleging that Taxotere caused permanent hair loss. A notice to the bar dated April 11 and made public the following week was issued by Acting Administrative Director of the Court Glenn A. Grant.
